As of 2024-12-12, the Intrinsic Value of Oncolytics Biotech Inc (ONC.TO) is
-1.79 CAD. This ONC.TO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.25 CAD, the upside of Oncolytics Biotech Inc is
-243.46%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-1.79 CAD
Intrinsic Value
ONC.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
Fair Value |
-1.79 - -1.79 |
-1.79 |
-243.46% |
P/E |
(0.03) - (0.07) |
(0.04) |
-102.9% |
DDM - Stable |
(3.37) - (20.49) |
(11.93) |
-1054.6% |
DDM - Multi |
(0.45) - (2.16) |
(0.75) |
-159.8% |
ONC.TO Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
96.34 |
Beta |
0.64 |
Outstanding shares (mil) |
77.07 |
Enterprise Value (mil) |
92.18 |
Market risk premium |
5.10% |
Cost of Equity |
8.51% |
Cost of Debt |
5.00% |
WACC |
8.49% |